Popular weight loss drugs such as Ozempic and Mounjaro now have the attention of the World Health Organization. Mike Armstrong explains why the WHO is now recommending GLP-1 medications for treating obesity, and why these drugs aren’t accessible to everyone.
Global National
Why WHO is now recommending GLP-1 drugs for obesity
More Videos
-
Global National: Dec. 24
-
How Trump is putting U.S. election integrity under pressure ahead of 2026 midterms
-
Epstein files: 3 Canadians mentioned in latest document release
-
Frozen Yukon and soaked California: Brutal weather hit before Christmas
-
Ukraine open to creating demilitarized zone in new draft peace plan
-
Japanese woman ‘marries’ ChatGPT AI character
You are viewing an Accelerated Mobile Webpage.
View Original Article